Bessemer Group
RVMD icon

Bessemer Group’s Revolution Medicines RVMD Stock Holding History

Bessemer Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$107K Sell
520
-4,442
-90% -$880K ﹤0.01% 1491
2026
Q2 		$929K Sell
4,962
-43,100
-90% -$6.3M ﹤0.01% 1010
2026
Q1 		$4.68M Sell
48,062
-69,600
-59% -$7.03M 0.01% 504
2025
Q4 		$9.37M Sell
117,662
-126,205
-52% -$8.28M 0.01% 338
2025
Q3 		$11.4M Buy
243,867
+296
+0.1% +$11.6K 0.02% 301
2025
Q2 		$8.96M Hold
243,571
– – 0.01% 311
2025
Q1 		$8.61M Buy
243,571
+13
+0% +$528 0.02% 310
2024
Q4 		$10.7M Hold
243,558
– – 0.02% 310
2024
Q3 		$11M Buy
243,558
+116
+0% +$5.05K 0.02% 313
2024
Q2 		$9.45M Hold
243,442
– – 0.02% 316
2024
Q1 		$7.85M Hold
243,442
– – 0.01% 330
2023
Q4 		$6.98M Hold
243,442
– – 0.01% 339
2023
Q3 		$6.74M Sell
243,442
-199,000
-45% -$5.9M 0.01% 320
2023
Q2 		$11.8M Hold
442,442
– – 0.03% 244
2023
Q1 		$9.6M Sell
442,442
-30,561
-6% -$753K 0.02% 258
2022
Q4 		$11.3M Sell
473,003
-3,847
-0.8% -$81.8K 0.03% 241
2022
Q3 		$9.4M Buy
476,850
+38,796
+9% +$853K 0.02% 251
2022
Q2 		$8.54M Hold
438,054
– – 0.02% 237
2022
Q1 		$11.2M Hold
438,054
– – 0.02% 211
2021
Q4 		$11M Hold
438,054
– – 0.02% 207
2021
Q3 		$12.1M Hold
438,054
– – 0.03% 213
2021
Q2 		$13.9M Hold
438,054
– – 0.03% 218
2021
Q1 		$20.1M Sell
438,054
-113,197
-21% -$5.08M 0.05% 205
2020
Q4 		$21.8M Sell
551,251
-124,167
-18% -$4.91M 0.06% 190
2020
Q3 		$23.5M Hold
675,418
– – 0.07% 179
2020
Q2 		$21.3M Hold
675,418
– – 0.07% 174
2020
Q1 		$14.8M Buy
+675,418
New +$18.7M 0.06% 197

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

Bessemer Group's RVMD Position: Q3 2026 in Review

Bessemer Group reduced its Revolution Medicines (RVMD) stake by 90% in Q3 2026, selling an estimated $880K and leaving 520 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #1491.

Bessemer Group first reported a position in RVMD in Q1 2020 and has held it in 27 quarters since. The position peaked at $23.5M in Q3 2020. 577 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Bessemer Group held 520 shares of Revolution Medicines worth $107K as of Q3 2026.
  • Bessemer Group sold 4,442 Revolution Medicines shares in Q3 2026, an estimated $880K.
  • Revolution Medicines made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #1491 holding.
  • Bessemer Group first reported a position in Revolution Medicines in Q1 2020 and has held it in 27 quarters since.
  • Bessemer Group's Revolution Medicines position peaked at $23.5M in Q3 2020.
  • 577 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.